About the Journal of Cancer Genetics and Biomarkers

Driving precision oncology forward through rigorous science, collaborative discovery, and equitable open access publishing.

Cancer evolves quickly—and so must the scholarship that guides its management. JCGB differentiates itself through a blend of quality, agility, and global reach:

• Precision focus: We specialize in the genetic and molecular hallmarks that underpin oncogenesis, resistance, and recurrence, offering depth that general oncology journals cannot provide.
• Integrated perspective: Submissions must address how their findings translate into patient benefit, clinical decision-making, or biomarker-driven trial design.
• Open access equity: Every JCGB article is freely available on publication day, amplified through cross-platform indexing and outreach to oncology networks on five continents.
• Collaborative curation: Our editorial board includes pioneering cancer geneticists, clinical oncologists, computational biologists, molecular pathologists, and regulatory scientists who guide fair and constructive peer review.
• Continuous innovation: Regular special issues, data challenges, and methodology spotlights keep the journal aligned with AI-driven analytics, liquid biopsy advances, cell therapy breakthroughs, and the evolving precision medicine landscape.

Maintaining credibility is paramount in precision oncology. JCGB’s editorial framework includes:

• Expert matching: Each manuscript is assigned to subject matter editors and reviewers with complementary expertise in genomics, bioinformatics, translational oncology, and clinical practice.
• Structured review templates: Reviewers assess novelty, analytical rigor, biomarker validation, and translational clarity, ensuring feedback is actionable and respectful.
• Ethics safeguard: All submissions undergo plagiarism screening, data availability checks, and, where applicable, evaluation of consent for genetic testing, clinical data sharing, and indigenous genomic data stewardship.
• Transparent decision-making: Editors provide detailed rationale for decisions, often accompanied by synthesis summaries that highlight consensus and divergence among reviewers.

JCGB encourages the submission of manuscripts that embrace FAIR (Findable, Accessible, Interoperable, Reusable) data principles. We offer guidance on depositing genomic and proteomic datasets in trusted repositories, sharing code, and presenting supplementary materials that enable reproducibility. Authors may include interactive dashboards, digital patient journey maps, or visual abstracts to help readers navigate complex analytical pipelines.

JCGB curates special issues that spotlight emerging frontiers. Themes in development include:

• “Spatial Multi-Omics for Solid Tumors” – mapping microenvironments at single-cell resolution to guide combination therapies.
• “Cancer Genetics in Indigenous and Under-Resourced Populations” – elevating community-led research and ethical frameworks.
• “Next-Generation Biomarkers for Minimal Residual Disease” – covering assays, analytics, and implementation science.
• “Digital Twins in Oncology” – evaluating computational models that predict treatment trajectories and optimize care pathways.

Prospective guest editors can learn more at the JCGB Propose a Special Issue page.

JCGB champions inclusive scholarship. We offer fee waivers for eligible authors, mentorship programs that pair early-career scientists with seasoned reviewers, and workshops targeting grant writing, data visualization, and community engagement. Our reviewer recognition program ensures feedback loops benefit both authors and assessors.

We collaborate with cancer centers, biotechnology firms, advocacy organizations, and data commons. JCGB welcomes proposals for joint dissemination campaigns, sponsored data challenges, and educational supplements. All partnerships adhere to strict editorial independence and disclosure policies.

We engage with our community through newsletters, webinars, social listening, and conference presence. Join us to hear about new special issues, data challenges, and collaborative opportunities. Share your perspective on how JCGB can better support the cancer genomics ecosystem—whether that is through additional author services, language editing support, or thematic focuses.

Last updated: September 2025. JCGB periodically revises its mission narrative to reflect community feedback, scientific advances, and evolving standards in cancer genomics publishing.